Here are four quick facts:
1. JPMorgan Chase analysts have a $15.52 price objective on the stock, suggesting a possible downside of 4.64 percent from the stock’s current price.
2. Smith & Nephew has a 12-month low of $14.40.
3. The 12-month high is $17.41.
4. The company has a market cap of $150 million.
More articles on devices:
7 new device launches & releases — January 26, 2015
VertiFlex raises $26.8M in funds: 3 points
Wells Fargo: LDR stock receives “market perform” rating — 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
